��ɫ��

��ɫ��

Donate To Research Join The AAN

Events

Resources For

Abstract Details

Title Haematologic Modifications as Markers of Response to Treatment in Multiple Sclerosis Patients Treated with Natalizumab

Topic Multiple Sclerosis

Presentation(s) (-)

Poster/Presentation
Number 288

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Nuala McNicholas, MBBS (St. Vincent'S University Hospital) PRESENTER	Dr. McNicholas has nothing to disclose.
Hugh Kearney, MD, PhD	Dr. Kearney has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen.
	No disclosure on file
Sinead Jordan (St. Vincents University Hospital)	Sinead Jordan has received personal compensation in the range of $0-$499 for serving as a Consultant for Biogen Idec. Sinead Jordan has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen Idec. Sinead Jordan has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Sinead Jordan has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis. Sinead Jordan has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Biogen Idec.
Deepti Sharma	No disclosure on file
	No disclosure on file
	No disclosure on file
Niall Tubridy, MD (St Vincent's University Hospital)	Dr. Tubridy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis .
Michael Hutchinson, MD (St Vincent's University Hospital)	Dr. Hutchinson has nothing to disclose.
	No disclosure on file